A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors

Grant

Date/time Interval

  • December 13, 2017 - December 12, 2018
  • Total Award Amount

  • 0.00
  • Direct Costs

  • 0.00
  • Sponsor Award Id

  • Contributor

  • Ana Galtarossa Xavier   Investigator  
  • Elizabeth Alva   Investigator  
  • Gregory Friedman M.D.   Investigator  
  • Kimberly Whelan M.D.   Investigator